Maggiore Christopher D.
SEC Form 4 insider trading activity
Maggiore Christopher D. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Jan 27, 2026.
On the most recent filing, Maggiore Christopher D. is listed as Director, 10% Owner at Zivo Bioscience, Inc. Inside the rolling window, Maggiore Christopher D. reported 1 open-market purchase totaling $15K in ZIVO and no open-market sales.
Companies traded
Other insiders at ZIVO
Insider Buying
$15K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 8, 2025 | ZIVO | Purchase | $284K |
Frequently asked questions
How many SEC Form 4 filings has Maggiore Christopher D. made?
Maggiore Christopher D. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Maggiore Christopher D. trade?
Maggiore Christopher D. has filed SEC Form 4 disclosures for 1 company, including ZIVO.
When was Maggiore Christopher D.'s most recent SEC Form 4 filing?
Maggiore Christopher D.'s most recent SEC Form 4 filing on Tracefour is dated Jan 27, 2026.
What is Maggiore Christopher D.'s total buy and sell value in the current window?
Inside the rolling retention window, Maggiore Christopher D. bought $15K and sold $0 based on SEC Form 4 filings.
What was Maggiore Christopher D.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,766 ZIVO shares on 2026-01-14, worth $15K, per SEC Form 4 filings.